Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04712500Phase 1Completed
Phase 1, randomised, open-label trial of AND017 in anemia (2 arms), sponsored by Kind Pharmaceuticals LLC. Primary endpoints: Maximum Plasma Concentration and Area Under the Concentration-Time Curve from Time Zero to Infinity. Started Jul 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04712500.